Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-23-000185
Filing Date
2023-02-28
Accepted
2023-02-28 16:27:21
Documents
79
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nwbo-20221231x10k.htm   iXBRL 10-K 3335840
2 EX-10.88 nwbo-20221231xex10d88.htm EX-10.88 48951
3 EX-23.1 nwbo-20221231xex23d1.htm EX-23.1 3608
4 EX-31.1 nwbo-20221231xex31d1.htm EX-31.1 12904
5 EX-32.1 nwbo-20221231xex32d1.htm EX-32.1 7512
6 GRAPHIC nwbo-20221231x10k001.jpg GRAPHIC 80983
  Complete submission text file 0001410578-23-000185.txt   14314128

Data Files

Seq Description Document Type Size
7 EX-101.SCH nwbo-20221231.xsd EX-101.SCH 94597
8 EX-101.CAL nwbo-20221231_cal.xml EX-101.CAL 62123
9 EX-101.DEF nwbo-20221231_def.xml EX-101.DEF 394557
10 EX-101.LAB nwbo-20221231_lab.xml EX-101.LAB 660075
11 EX-101.PRE nwbo-20221231_pre.xml EX-101.PRE 567491
73 EXTRACTED XBRL INSTANCE DOCUMENT nwbo-20221231x10k_htm.xml XML 2934281
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

EIN.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35737 | Film No.: 23685916
SIC: 2834 Pharmaceutical Preparations